ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Cuproptosis-related genes score: A predictor for hepatocellular carcinoma prognosis, immunotherapy efficacy, and metabolic reprogramming

Nie, Guilin; Peng, Dingzhong; Wen, Ningyuan; Wang, Yaoqun; Lu, Jiong*; Li, Bei*南方医科大学; 四川大学
Frontiers in Oncology2023-2-9DOI: 10.3389/fonc.2023.1096351
11阅读
引用收藏
分享

摘要

BackgroundCuproptosis is a newly identified type of programmed cell death, characterized by aggregation of mitochondrial lipoylated proteins and the destabilization of Fe-S cluster proteins triggered by copper. However, its role in hepatocellular carcinoma (HCC) remains unclear. MethodsWe analyzed the expression and prognostic significance of cuproptosis-related genes using the data obtained from TCGA and ICGC datasets. A cuproptosis-related genes (CRG) score was constructed and validated via least absolute shrinkage and selection operator (LASSO) Cox regression, multivariate Cox regression and nomogram model. The metabolic features, immune profile and therapy guidance of CRG-classified HCC patients were processed via R packages. The role of kidney-type glutaminase (GLS) in cuproptosis and sorafenib treatment has been confirmed via GLS knockdown. ResultsThe CRG score and its nomogram model performed well in predicting prognosis of HCC patients based on the TCGA cohort (training set), ICGC cohort and GEO cohort (validation set). The risk score was proved as an independent predictor for overall survival (OS) of HCC. The area under the curves (AUCs) of the model in the training and validation cohorts were all around 0.83 (TCGA, 1- year), 0.73 (TCGA, 3- year), 0.92 (ICGC, 1- year), 0.75 (ICGC, 3- year), 0.77 (GEO, 1- year), 0.76(GEO, 3- year). Expression levels of metabolic genes and subtypes of immune cells, and sorafenib sensitiveness varied significantly between the high-CRG group and low-CRG group. One of the model-included gene, GLS, might be involved in the process of cuproptosis and sorafenib treatment in HCC cell line. ConclusionThe five cuproptosis-related genes model contributed to prognostic prediction and provided a new sight for cuproptosis-related therapy in HCC.

学科与关键词

关键词
cuproptosishepatocellular carcinomaprognostic modelsorafenibGLS
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2023-02-09
卷期
第 13 卷
页码
1096351
DOI
10.3389/fonc.2023.1096351
成果收录
SCIE
资助标注
1.3.5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University [20HXFH021]; National Natural Science Foundation of China [82002578]

作者

  • N

    Nie, Guilin (第一作者)

    sichuan univ

  • P

    Peng, Dingzhong

    southern med univ

查看全部 6 位作者收起作者
  • W

    Wen, Ningyuan

    sichuan univ

  • W

    Wang, Yaoqun

    sichuan univ

  • L

    Lu, Jiong (通讯)

    sichuan univ

  • L

    Li, Bei (通讯)

    sichuan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417